Description
IGF-1 DES is a truncated synthetic peptide compound engineered for laboratory research. The molecule consists of 67 amino acids, demonstrating specific receptor binding properties in experimental models. Research indicates unique molecular pathway interactions with enhanced binding affinity in controlled studies. The compound lacks the first three N-terminal amino acids of the parent molecule, resulting in distinct chemical properties.